Unlock instant, AI-driven research and patent intelligence for your innovation.

Compound used as HPK1 kinase inhibitor and preparation method and application thereof

A compound and hydrate technology, applied in the field of HPK1 inhibitors and its preparation, to achieve high activity and high selectivity

Pending Publication Date: 2022-04-12
CHINA PHARM UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are currently no marketed drugs targeting the hematopoietic progenitor kinase (HPK1)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound used as HPK1 kinase inhibitor and preparation method and application thereof
  • Compound used as HPK1 kinase inhibitor and preparation method and application thereof
  • Compound used as HPK1 kinase inhibitor and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0147] Example 1.3-((6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino)-5-phenylamino-1,2,4- Triazine-6-carboxamide

[0148]

[0149] Step 1: Add DIPEA (667mg, 5.16mmol) to a solution of ethyl 5-chloro-3-methylthio-1,2,4-triazine-6-carboxylate (600mg, 2.57mmol) in NMP (20ml) And aniline (287mg, 3.08mmol), react at room temperature for 1h. After the reaction, add water, extract three times with EA, combine the organic phase and wash with saturated brine, take the organic phase and dry it with anhydrous sodium sulfate, filter it with suction, spin dry to obtain 3-methylthio-5-phenylamino-1, Ethyl 2,4-triazine-6-carboxylate was directly used in the next reaction without further purification. MS(ESI):M / Z=291.09[M+H] + .

[0150] Step 2: Add 3-methylthio-5-phenylamino-1,2,4-triazine-6-carboxylic acid ethyl ester obtained in the previous step to 7N amine in methanol solution (20ml), and mix with room temperature Stir overnight. After the reaction, spin to dry unde...

Embodiment 2

[0152] Example 2.3-((6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino)-5-((2-(methoxymethyl )phenyl)amino)-1,2,4-triazine-6-carboxamide

[0153]

[0154] In a similar manner to that described in Example 1, using o-aminobenzyl alcohol as a raw material instead of aniline, a pale yellow product was finally prepared (yield: 2.1%). MS(ESI):M / Z=436.21[M+H] + . 1 H NMR (400MHz, DMSO-d 6 )δ11.43(s,1H),9.11(s,1H),8.42(s,1H),7.82(s,1H),7.61(d,J=7.1Hz,1H),7.43(s,1H), 7.33–7.26(m,2H),7.18–7.05(m,1H),6.81(s,1H),5.15(t,J=5.5Hz,1H),4.61(d,2H),3.71(s,3H) ,3.51(s,2H),2.85(t,J=5.1Hz,2H),2.74(d,2H),2.42(s,3H).

Embodiment 3

[0155] Example 3.3-((6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino)-5-((2-(methoxymethyl )phenyl)amino)-1,2,4-triazine-6-carboxamide

[0156]

[0157] In a similar manner to that described in Example 1, using 2-(methoxymethyl)aniline as a starting material instead of aniline, a pale yellow product was prepared (yield: 2.7%). MS(ESI):M / Z=450.22[M+H] + . 1 H NMR (400MHz, DMSO-d 6 )δ11.43(s,1H),9.03(s,1H),8.43(s,1H),7.83(s,1H),7.63(d,J=7.3Hz,1H),7.40(s,1H), 7.34–7.25(m,2H),7.17–7.05(m,1H),6.83(s,1H),4.83(s,2H),3.77(s,3H),3.50(s,2H),3.28(s, 2H) 2.85(t, J=5.4Hz, 2H), 2.83(d, 2H), 2.26(s, 3H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound used as an HPK1 kinase inhibitor as well as preparation and application of the compound. The structure of the compound is as shown in a formula I which is described in the specification. The compound has excellent HPK1 inhibitory activity, so that the compound can be used for preparing pharmaceutical compositions for treating cancers and other HPK activity related diseases.

Description

technical field [0001] The invention relates to a kinase inhibitor and its preparation method and application, in particular to an HPK1 inhibitor and its preparation method and application. Background technique [0002] Surgical resection, radiotherapy, chemotherapy, and small-molecule targeted drugs are the main modalities used to treat cancer. Unfortunately, for many forms of cancer or tumors, surgical resection is often not a viable option, and radiotherapy and chemotherapy play an important role in killing tumor cells At the same time, it can also damage healthy cells. In addition, the instability of the tumor cell genome promotes the mutation of tumor cells, which further leads to rapid changes in the cancer genome, making it resistant to drugs that specifically target the tumor, which makes cancer treatment difficult. In recent years, killing tumor cells through the immune system of cancer patients and improving the body's anti-tumor immunity is a new strategy for can...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/12C07D401/14C07D403/12C07D405/14C07D413/14C07D455/04C07F9/6558A61P35/00A61K31/53A61K31/675
Inventor 蒋晟肖易倍郝海平周立昕叶秀全张阔军王天雨王凯振唐鹤章翔宇
Owner CHINA PHARM UNIV